How AI is moving from drug discovery into clinical trials, operations and commercial strategy, and why pharma must adopt a holistic, ecosystem view to win.
AI Reshaping Pharma: From Discovery to Strategic Advantage Read More »
Insilico’s AI-discovered Rentosertib (ISM001-055) wins IND for inhalation Phase I in IPF, validating Pharma.AI’s faster, repeatable drug discovery approach.
Rentosertib IND Cleared for Inhalation Study in IPF — AI-Discovered by Insilico Read More »
The Health + AI Insiders Tech Show, hosted by Insiders Intelligence Group, took place yesterday 29 April 2026
at Big Penny Social, London.
That’s a Wrap: The UK’s First Health + AI Tech Show Read More »
Insilico Medicine convenes an industry-first Longevity Board to marry Big Pharma expertise with AI drug discovery, targeting dual-purpose therapies to extend healthspan.
Amazon’s AWS Bio Discovery pairs foundation models, agentic assistants and CRO wet labs to accelerate early-stage drug discovery for pharma and biotech.
Amazon Launches AWS Bio Discovery: AI-Powered ‘Lab-in-the-Loop’ to Speed Drug R&D Read More »
Explore how AI-native Electronic Lab Notebooks convert record-keeping into proactive research assistance, integrating tools and data to accelerate drug discovery.
AI-Native ELNs: How Intelligent Lab Notebooks Speed Drug Discovery Read More »
Latest on Verily’s $300M raise, Latent Labs’ Latent-X2, Insilico’s PandaClaw, and BMS-insitro ALS work. What these moves mean for AI-driven drug discovery.
AI Drug Discovery’s Momentum: Key Updates from the Frontier Read More »
EMA and FDA publish joint principles for safe AI across the medicines lifecycle, guiding risk-based validation, data governance, human oversight and patient safety.
Global Standards for AI in Drug Discovery: EMA and FDA Principles Read More »
A concise overview of Europe’s AI-driven drug discovery market: market trajectory, key technologies, leading countries, main challenges, and strategic opportunities.
Europe’s AI Drug Discovery Surge: Trends, Players, and What’s Next Read More »
How pharma can convert fragmented legacy data into a living scientific memory to accelerate AI-driven drug discovery and secure lasting competitive advantage.
AI Drug Discovery’s Hidden Power: Transforming Legacy Data into Living Scientific Memory Read More »
